Foundations & philanthropic institutions
Support individual treatments, medical domains, regional access programs, institutional development or research.
Get involved · Partner with us
Institutions that make access possible.
Foundations, companies, public institutions and researchers can help AAM reduce barriers to advanced medicine — under strict independence rules.
Who can partner
Four kinds of partner
Companies
Financial or in-kind support from pharmaceutical, medical technology, biotechnology, healthcare and technology companies and other socially responsible businesses.
Public & multilateral institutions
National and regional public institutions, international development organizations, health-focused programs, and European and international foundations.
Universities & research centers
Collaboration on emerging treatments, clinical research monitoring and access gaps.
Independence
Rules every partner accepts
- Corporate contributions never determine medical eligibility or treatment recommendations.
- Commercial conflicts of interest are disclosed and managed.
- Partners cannot select individual beneficiaries or override eligibility decisions.
- Research partnerships must not compromise patient independence.
Not a marketplace
AAM’s medical decisions are independent of donors and commercial interests. A partnership never buys priority, access or influence over a patient’s pathway.
Ways to work together
Models of partnership
Program or domain funding
Support a defined program or medical domain, or a future dedicated fund.
Co-financing
Share the cost of individual patient pathways with AAM.
In-kind support
Technology, expertise, services or capacity.
Research collaboration
Understand innovation and the gaps between research and access.
Hospitals & clinics
Looking to join as a care provider?
Hospitals, specialist clinics and diagnostic centers can become AAM institutions that AAM cites, contacts and refers patients to.
Start the conversation